YOU SEARCHED BY...
SEARCH BY...
Country
- Australia(4)
- Canada(15)
- China(1)
- Denmark(1)
- France(1)
- Hong Kong(1)
- Hungary(1)
- India(5)
- Italia (1)
- Mexico(1)
- Peru(1)
- Romania(1)
- Slovenia(1)
- Spain(2)
- Sweden(1)
- Switzerland(1)
- Taiwan(1)
- The Netherlands(1)
- United Kingdom(6)
- United States(101)
Contract Service Directory
Thymed GmbH
Company Headquarters
Mikroforum Ring 2
Wendelsheim, D-55234
Germany
Contract Service Directory
Related Content
-
Breaking News | Drug Development | Drug Discovery | Industry News
Rentschler Biopharma to Support Albert Einstein Discovery Center
Donates 50,000 Euros to support the creation of the discovery and activity center in Ulm.09.22.21
-
Breaking News | Promotions & Moves
Rentschler Biopharma Appoints Dr. Christian Schetter as Chief Scientific Officer
Schetter has a proven track record across the entire biopharmaceutical value chain.09.20.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Repligen and Navigo Launch Antibody Technology Platform
Introduce industry-first protein A ligand for purification of pH sensitive antibodies.09.10.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
GeneQuine, Exothera Enter Gene Therapy Partnership
To support the next stage of osteoarthritis gene therapy development program.09.10.21
-
Bio News | Breaking News | Collaborations & Alliances | Drug Discovery | Industry News
Boehringer Ingelheim, Twist Bioscience Enter Antibody Discovery Collaboration
Research collaboration covers multiple antibody research programs.09.10.21
-
Breaking News | Collaborations & Alliances | Drug Development
GeneQuine Contracts Exothera to Support the Development of Its Osteoarthritis Gene Therapy
GQ-303, the gene therapy candidate, turns joint cells into factories for production of the therapeutic protein proteoglycan 4.09.10.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
CEVEC, UCB Ink AAV Mfg. Technology Agreement
UCB will use of CEVEC’s ELEVECTA AAV manufacturing technology in gene therapy.09.07.21
-
Breaking News | Drug Development | R&D
Veraxa Biotech and Indivumed to Jointly Develop Precision Oncology Antibody Drugs
Aim to discover new possibilities for cancer treatment in the shortest-possible time.08.10.21
-
Breaking News | cGMP Manufacture | Clinical Trial Materials | Fill/Finish | Industry News | Lyophilization
Vetter’s New Clinical Mfg. Site Now Fully Integrated
Expands clinical capacity to address growing market demand.07.21.21
-
-
Breaking News | cGMP Manufacture | Drug Development | Industry News
Hermes Pharma Announces Spin-out from Hermes Arzneimittel
CDMO specializes in the development and manufacture of user-friendly oral dosage forms for healthcare companies around the world.07.02.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Rentschler Expands Complex Antibodies Production in Germany
Expands capacity with 2,000-liter bioreactor to address increasing demand for complex antibodies.06.30.21
-
Breaking News | Drug Development
CureVac Appoints Dr. Malte Greune as COO
Dr. Florian von der Mülbe will shift focus exclusively toward the expansion and accelerated development of The RNA Printer.06.30.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News | Process Development
Catalent to Acquire RheinCell Therapeutics
Strengthens path towards industrialization of induced pluripotent stem cell-based therapies.06.25.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
VERAXA and Quadira Enter ADC Development Partnership
To develop a suite of novel ADCs for the treatment of oncological conditions.06.15.21
-
Promotions & Moves
Selexis SA Appoints Hoffmann-Hecht CBO
Dr. Hoffmann-Hecht will serve on the executive leadership team and will report to Selexis CEO Dirk Lange.Kristin Brooks 06.02.21
-
Breaking News | Industry News | Promotions & Moves
ACG Appoints Senior Executives in Europe
Daniel Illmer and Afsaneh Nakhavoli join the company’s R&D facility in Germany.Charles Sternberg, Assistant Editor 05.27.21
-
Biologics, Proteins, Vaccines | Breaking News | Industry News
Pfizer, BioNTech to Supply Additional COVID-19 Vax Doses to Turkey
To supply 60 million additional doses of the companies’ COVID-19 vaccine, with an option for an additional 30 million doses to be delivered in 2021.Kristin Brooks 05.20.21
-
Breaking News | Industry News | Vials
HERMA US Delivers Wrap-around Labelers to Catalent
Will support production of biologics, including COVID-19 vaccines.Kristin Brooks 05.18.21
-
Breaking News | Promotions & Moves
BioNTech SE Appoints Jens Holstein as CFO
Holstein succeeds Dr. Sierk Poetting.Charles Sternberg, Assistant Editor 05.18.21
-
Breaking News | Financial Reports
Gilead Revenues up 16% in the Quarter
Veklury drives growth in the quarter, offsetting significant declines in HIV, HCV franchises.Kristin Brooks 04.30.21
-
Breaking News | cGMP Manufacture | Collaborations & Alliances
Vetter, Rentschler Biopharma Advance Strategic Alliance
Sets up a governance structure and implements guidelines for joint manufacturing services to support clients.Kristin Brooks 04.28.21
-
Aseptic Processing | Breaking News | Collaborations & Alliances | Industry News
Steriline Delivers New Manufacturing Line to Bess Pro
Provided a turnkey line, fully operating and ready to perform at full capacity.Charles Sternberg, Assistant Editor 03.31.21
-
Breaking News | Industry News | Promotions & Moves
Rentschler Biopharma Names Martin Kessler as New CEO in U.S.
Will drive company-wide transformation and lead the ongoing expansion at the U.S. site.Tim Wright, Editor, Contract Pharma 03.31.21
-
Breaking News | Formulation Development | Industry News
Rentschler, Leukocare Extend Service Offering with U.S. Site
Opens Leukocare’s U.S. development labs and offices at Rentschler's facility in the Greater Boston area, where the two companies will work together.Kristin Brooks 03.22.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Facilities | Industry News | Parenterals
Genopis Renamed Wacker Biotech US
Plasmid DNA contract manufacturer was recently acquired by Wacker.Tim Wright, Editor, Contract Pharma 03.19.21
-
Breaking News | Industry News
Romaco Acquires STE Tecpharm
Strengthens Romaco’s processing business with Tecpharm’s drum coaters, coupled with conventional granulation lines and Wurster fluid bed systems.Kristin Brooks 03.18.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Takeda and IDT Support Manufacturing of J&J’s COVID-19 Vaccine
Will make manufacturing capacity available at IDT’s facilities in Germany to manufacture the single-shot COVID-19 vaccine.Tim Wright, Editor, Contract Pharma 03.15.21
-
Breaking News | cGMP Manufacture | Drug Development | Industry News
Vetter Establishes Office in China
Additional office in Asia Pacific region to promote development of new business in China.Kristin Brooks 03.08.21
-
Drug Delivery | Parenterals
Injectable Drug Delivery Trends
How medication trends are driving the shift to patient-friendly drug delivery systems.Peter Soelkner, Managing Director, Vetter 03.01.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News | Scale-up/Technology Transfer
MaxiVAX, Minaris Enter Cell Therapy Mfg. Agreement
Minaris will provide GMP manufacturing, freezing and shipping of the MVX-ONCO-2 capsules from its site near Munich, Germany.Kristin Brooks 02.22.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News
Catalent, Trizell Enter Cell Therapy Deal
Sign development and manufacturing agreement with for macrophage-based advanced cell therapy.Tim Wright, Editor, Contract Pharma 02.08.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
RheinCell Therapeutics Achieves GMP Certification
Marks a milestone for the evolution of the company.Contract Pharma Staff 01.13.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Biogen Licenses CEVEC AAV Mfg. Technology
Biogen gains rights to ELEVECTA Technology for manufacturing of gene therapy products.Contract Pharma Staff 01.08.21
-
Breaking News | Industry News
Gilead to Acquire MYR GmbH for €1.15B
Gains Hepcludex, a first-in-class treatment for HDV; anticipates accelerated global launch as a result of the acquisition.Contract Pharma Staff 12.10.20
-
Breaking News | Collaborations & Alliances | CRO News | Drug Discovery | Industry News | R&D
Evotec and Sartorius Partner with Curexsys
Leverage IPSC platform for scalable manufacturing of Curexsys' exosome-based therapeutics.Contract Pharma Staff 12.09.20
-
Bormioli Pharma Acquires ISO GmbH
Broadens its range of packaging for parenteral drugs.Contract Pharma Staff 12.01.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Vibalogics Establishes U.S. Presence
Will open virotherapy facility in Boston and plans to invest $150 million.Contract Pharma Staff 11.16.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
CEVEC, Roche Ink ELEVECTA Technology License Agreement
Allows Roche to use CEVEC's ELEVECT Technology for AAV vector manufacturing for its portfolio of gene therapy products.Contract Pharma Staff 11.11.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Minaris Invests $64.5M to Expand Cell and Gene Mfg. Facilities
New buildings near Munich, Germany and Yokohama, Japan will more than double capacity for commercial manufacturing of regenerative medicines.Contract Pharma Staff 11.02.20
-
Breaking News | Industry News | Promotions & Moves
Valicare Expands Service Portfolio
Recruits Dr. Christin Erbach as senior GMP consultant.Contract Pharma Staff 10.28.20
-
Facilities
Vetter Moves Into New HQ
€50 million investment integrates the latest construction and environmental standards.Contract Pharma Staff 10.21.20
-
Bio News | Bioassay Development | Breaking News | Collaborations & Alliances | CRO News | Industry News
Reaction Biology and 4HF Biotec Collaborate
Announce new cell-based service offering that combines their technologies.Contract Pharma Staff 10.21.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
CEVEC, Rznomics Ink License Agreement for CAP Technology
Rznomics will use CEVEC’s cell line technology with its trans-splicing ribozyme technology for manufacturing gene therapies targeting various cancers.10.20.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Industry News
Rentschler Biopharma and ATUM Ink Licensing Agreement
Leap-In Transposase technology will be integrated into Rentschler’s in-house process to complement existing CLD offering.Contract Pharma Staff 10.15.20
-
Aseptic Processing | Fill/Finish
A Holistic Cleanroom Concept: Higher Quality and Greater Flexibility
Overcoming today’s aseptic fill-and-finish process challenges.Ute Schleyer, Project Manager, Site & Plant Development, Vetter 10.14.20
-
Bio News | Breaking News | Facilities | Industry News
CellGenix Expands Facility
Meets the growing demand for GMP raw materials.Contract Pharma Staff 10.13.20
-
Breaking News | Drug Delivery | Industry News | Solid Dosage/Creams/Ointments
Evonik Launches New Oral Drug Delivery Technology
For enteric protection and rapid release in the upper small intestine.Contract Pharma Staff 10.06.20
-
Breaking News | Promotions & Moves
Takeda Appoints Commercial Ops Head
Platford to lead expansion efforts in emerging marketsKristin Brooks 03.20.14
-
Breaking News | Industry News
-
Breaking News | Fill/Finish | Industry News
